Casgevy launch date?

When is Casgevy (exagamglogene autotemcel) expected to launch?

Casgevy’s launch timing is tied to regulatory approvals and rollout in specific countries. The drug was the subject of major first approvals in 2023, which set the basis for its commercial availability after that point.

What was the first approval date that led to Casgevy’s launch?

Casgevy received initial authorization in the UK in late 2023, which is commonly treated as the start of its real-world launch in that market. Commercial rollout then followed through provider centers approved to deliver the therapy.

When did Casgevy become available in the U.S.?

For U.S. availability, launch depends on FDA approval and then the pace of patient scheduling and manufacturing supply. That launch date is therefore best thought of as the post-approval period rather than a single manufacturing milestone.

Why do “launch date” answers differ by source?

Different outlets report different “launch” dates because they may refer to:
- First regulatory approval (authorization date)
- First treatment of patients (clinical center start)
- Commercial launch in a particular country
- Broader rollout after initial supply constraints

If you tell me which country you mean by “launch date” (UK, U.S., EU, or another), I can give the most accurate date for that market.